High frequency of BRCA1/2 and p53 somatic inactivation in sporadic ovarian cancer

Journal of Genetics

Volumn 86, Issue 2, 2007, Pages 169-171

  Zikan, Michal ^a,b   Janatova, Marketa ^a   Pavlista, David ^b   Pohlreich, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

BRCA1; BRCA2; Loss of heterozygosity; p53; Sporadic ovarian cancer

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOMA; FEMALE; GENE FREQUENCY; GENE SILENCING; GENETICS; HETEROZYGOSITY LOSS; HUMAN; MIDDLE AGED; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENE SILENCING; GENES, BRCA1; GENES, BRCA2; GENES, P53; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; OVARIAN NEOPLASMS;

EID: 35549012857     PISSN: 00221333     EISSN: 00221333     Source Type: Journal    
DOI: 10.1007/s12041-007-0022-y     Document Type: Article

References (13)

1. Chan K. Y. K., Ozcelik H., Cheung A. N. Y., Ngan H. Y. S. and Khoo U. S. 2002 Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res. 62, 4151-4156.
2. Esteller M., Silva J. M., Dominguez G., Bonilla F., Matias-Guiu X., Lerma E. et al. 2000 Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumours. J. Natl. Cancer Inst. 92, 564-569.
3. Geisler J. P., Rathe J. A., Hattermann-Zogg M. A. and Buller R. E. 2002 BRCA1 dysfunction is common in ovarian cancer. J. Natl. Cancer Inst. 94, 61-67.
4. Gras E., Cortes J., Diez O., Alonso C., Matias-Guiu X. and Prat J. 2001 Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumours. Cancer 92, 787-795.
5. Hilton J. L., Geisler J. P., Rathe J. A., Hattermann-Zogg M. A., DeYoung B. and Buller R. E. 2002 Inactivation of BRCA1 and BRCA2 in ovarian cancer. J. Natl. Cancer Inst. 94, 1396-1406.
6. Janatova M., Pohlreich P. and Matous B. 2003 Detection of the most frequent mutations in BRCA1 gene on polyacrylamide gels containing Spreadex Polymer NAB. Neoplasma 50, 246-250.
7. McCoy M. L., Mueller C. R. and Roskelley C. D. 2003 The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer. Reprod. Biol. Endocrin. 1, 72.
8. Miyamoto K., Fukutomi T., Asada K., Wakazono K., Tsuda H., Asahara T. et al. 2002 Promoter hypermethylation and posttranscriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers. Jpn. J. Clin. Oncol. 32, 79-84.
9. Pohlreich P., Stribrna J., Kleibl Z., Zikan M., Kalbacova R., Petrazelka L. and Konopasek B. 2003 Mutations of the BRCA1 gene in hereditary breast and ovarian cancer in the czech Republic. Med. Princ. Pract. 12(1), 23-29.
10. Szabo C. L. and King M. C. 1997 Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet. 60, 1013-1020.
11. Takahashi H., Chiu H. C., Bandera C. A., Behbakht K., Liu P. C. and Cough F. J. 1996 Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res. 56, 2738-2741.
12. Verma M. and Srivastava S. 2002 Epigenetics in cancer: implications for early detection and prevention. Lancet Oncol. 3, 755-763.
13. Zikan M., Pohlreich P. and Stribrna J. 2005 Mutational analysis of the BRCA1 gene in 30 Czech ovarian cancer patients. J. Genet. 84, 63-67.